<VariationArchive RecordType="classified" VariationID="21687" VariationName="NM_024529.5(CDC73):c.766_767del (p.Val256fs)" VariationType="Deletion" Accession="VCV000021687" Version="5" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-02-18" DateCreated="2013-05-03" MostRecentSubmission="2022-09-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="34539" VariationID="21687">
      <GeneList>
        <Gene Symbol="CDC73" FullName="cell division cycle 73" GeneID="79577" HGNC_ID="HGNC:16783" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193122031" stop="193254815" display_start="193122031" display_stop="193254815" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193091087" stop="193223944" display_start="193091087" display_stop="193223944" Strand="+" />
          </Location>
          <OMIM>607393</OMIM>
          <Haploinsufficiency last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_024529.5(CDC73):c.766_767del (p.Val256fs)</Name>
      <CanonicalSPDI>NC_000001.11:193147901:TGT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193147902" stop="193147903" display_start="193147902" display_stop="193147903" variantLength="2" positionVCF="193147901" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193117032" stop="193117033" display_start="193117032" display_stop="193117033" variantLength="2" positionVCF="193117031" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>V256fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.193117033_193117034del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.193117033_193117034del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.193147903_193147904del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.193147903_193147904del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012691.1" sequenceAccession="NG_012691" sequenceVersion="1" change="g.30946_30947del">
            <Expression>NG_012691.1:g.30946_30947del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024529.5" sequenceAccession="NM_024529" sequenceVersion="5" change="c.766_767del" MANESelect="true">
            <Expression>NM_024529.5:c.766_767del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_078805.3" sequenceAccession="NP_078805" sequenceVersion="3" change="p.Val256fs">
            <Expression>NP_078805.3:p.Val256fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_507" sequenceAccession="LRG_507">
            <Expression>LRG_507:g.30946_30947del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_507t1" sequenceAccession="LRG_507t1">
            <Expression>LRG_507t1:c.766_767del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_507p1" sequenceAccession="LRG_507p1" change="p.Val256Lysfs">
            <Expression>LRG_507p1:p.Val256Lysfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA342370" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607393.0011" DB="OMIM" />
        <XRef Type="rs" ID="80356650" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024529.5(CDC73):c.766_767del (p.Val256fs) AND Parathyroid carcinoma" Accession="RCV000020885" Version="5">
        <ClassifiedConditionList TraitSetID="834">
          <ClassifiedCondition DB="MedGen" ID="C0687150">Parathyroid carcinoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024529.5(CDC73):c.766_767del (p.Val256fs) AND Hyperparathyroidism 2 with jaw tumors" Accession="RCV002260511" Version="1">
        <ClassifiedConditionList TraitSetID="833">
          <ClassifiedCondition DB="MedGen" ID="C1704981">Hyperparathyroidism 2 with jaw tumors</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2004-04-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-05-03" MostRecentSubmission="2022-09-24">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15070940</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301744</ID>
          <ID Source="BookShelf">NBK3789</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="834" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3270" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Parathyroid carcinoma</ElementValue>
                <XRef ID="Parathyroid+carcinoma/5598" DB="Genetic Alliance" />
                <XRef ID="HP:0006780" DB="Human Phenotype Ontology" />
                <XRef ID="255037004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parathyroid cancer</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CDC73-Related Parathyroid Carcinoma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parathyroid gland carcinoma</ElementValue>
                <XRef ID="MONDO:0012004" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PRTC</ElementValue>
                <XRef Type="MIM" ID="608266" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7329" />
                <XRef ID="7329" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of CDC73-related disorders includes the following phenotypes: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Primary hyperparathyroidism, the main finding of HPT-JT syndrome, occurs in up to 95% of affected individuals; onset is typically in late adolescence or early adulthood. HPT-JT-associated primary hyperparathyroidism is usually caused by a single parathyroid adenoma. In approximately 10%-15% of individuals, primary hyperparathyroidism is caused by parathyroid carcinoma. Ossifying fibromas of the mandible or maxilla, also known as cementifying fibromas and cemento-ossifying fibromas, occur in 30%-40% of individuals with HPT-JT syndrome. Although benign, these tumors can be locally aggressive and may continue to enlarge if not treated. Approximately 20% of individuals with HPT-JT syndrome have kidney lesions, most commonly cysts; renal hamartomas and (more rarely) Wilms tumor have also been reported. Benign and malignant uterine tumors appear to be common in women with HPT-JT syndrome. Parathyroid carcinoma. Most parathyroid carcinomas are functional, resulting in hyperparathyroidism and a high serum calcium level; however, nonfunctioning parathyroid carcinomas are also rarely described in individuals with a CDC73-related disorder. A germline CDC73 pathogenic variant has been identified in 20%-29% of individuals with apparently sporadic parathyroid carcinoma. Familial isolated hyperparathyroidism (FIHP). FIHP is characterized by primary hyperparathyroidism without other associated syndromic features. Individuals with CDC73-related FIHP tend to have a more severe clinical presentation and younger age of onset than individuals with FIHP in whom a CDC73 pathogenic variant has not been identified.</Attribute>
                <XRef ID="NBK3789" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301744</ID>
                <ID Source="BookShelf">NBK3789</ID>
              </Citation>
              <XRef ID="143" DB="Orphanet" />
              <XRef ID="C0687150" DB="MedGen" />
              <XRef ID="MONDO:0012004" DB="MONDO" />
              <XRef Type="MIM" ID="608266" DB="OMIM" />
              <XRef Type="primary" ID="HP:0006780" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="833" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5289" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hyperparathyroidism 2</ElementValue>
                <XRef ID="Hyperparathyroidism+2/8598" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERPARATHYROIDISM, FAMILIAL PRIMARY, WITH MULTIPLE OSSIFYING JAW FIBROMAS</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERPARATHYROIDISM-JAW TUMOR SYNDROME, HEREDITARY</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hyperparathyroidism 2 with jaw tumors</ElementValue>
                <XRef ID="MONDO:0007768" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HPT-JT</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HRPT2</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10829" />
                <XRef ID="10829" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of CDC73-related disorders includes the following phenotypes: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Primary hyperparathyroidism, the main finding of HPT-JT syndrome, occurs in up to 95% of affected individuals; onset is typically in late adolescence or early adulthood. HPT-JT-associated primary hyperparathyroidism is usually caused by a single parathyroid adenoma. In approximately 10%-15% of individuals, primary hyperparathyroidism is caused by parathyroid carcinoma. Ossifying fibromas of the mandible or maxilla, also known as cementifying fibromas and cemento-ossifying fibromas, occur in 30%-40% of individuals with HPT-JT syndrome. Although benign, these tumors can be locally aggressive and may continue to enlarge if not treated. Approximately 20% of individuals with HPT-JT syndrome have kidney lesions, most commonly cysts; renal hamartomas and (more rarely) Wilms tumor have also been reported. Benign and malignant uterine tumors appear to be common in women with HPT-JT syndrome. Parathyroid carcinoma. Most parathyroid carcinomas are functional, resulting in hyperparathyroidism and a high serum calcium level; however, nonfunctioning parathyroid carcinomas are also rarely described in individuals with a CDC73-related disorder. A germline CDC73 pathogenic variant has been identified in 20%-29% of individuals with apparently sporadic parathyroid carcinoma. Familial isolated hyperparathyroidism (FIHP). FIHP is characterized by primary hyperparathyroidism without other associated syndromic features. Individuals with CDC73-related FIHP tend to have a more severe clinical presentation and younger age of onset than individuals with FIHP in whom a CDC73 pathogenic variant has not been identified.</Attribute>
                <XRef ID="NBK3789" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CDC73-Related Disorders</Attribute>
                <XRef ID="226120" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301744</ID>
                <ID Source="BookShelf">NBK3789</ID>
              </Citation>
              <XRef ID="99880" DB="Orphanet" />
              <XRef ID="C1704981" DB="MedGen" />
              <XRef ID="MONDO:0007768" DB="MONDO" />
              <XRef Type="MIM" ID="145001" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23595" SubmissionDate="2018-07-24" DateLastUpdated="2018-07-27" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607393.0011_HYPERPARATHYROIDISM-JAW TUMOR SYNDROME" title="CDC73, 2-BP DEL_HYPERPARATHYROIDISM-JAW TUMOR SYNDROME" />
        <ClinVarAccession Accession="SCV000023595" DateUpdated="2018-07-27" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 6 Roma families from Portugal with hyperparathyroidism-jaw tumor syndrome (HRPT2; 145001), Cavaco et al. (2004) identified a 2-bp deletion in exon 8 of the HRPT2 gene (either TG involving codons 255 and 256 or GT involving codon 256) in 11 affected individuals. The mutation was also found in 19 of 45 asymptomatic individuals (age range, 12 to 74 years) who shared the affected haplotype, suggesting a low age-related penetrance for HPT-JT in these families. The mutation was predicted to lead to a frameshift encoding 9 missense amino acids followed by a premature stop at codon 265. Haplotype analysis suggested that the families were likely to be related through a recent common ancestor.</Attribute>
              <Citation>
                <ID Source="PubMed">15070940</ID>
              </Citation>
              <XRef DB="OMIM" ID="145001" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDC73" />
          </GeneList>
          <Name>CDC73, 2-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607393.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPERPARATHYROIDISM-JAW TUMOR SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="41479" SubmissionDate="2013-04-30" DateLastUpdated="2022-09-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_024529.3:c.766_767delGT_NBK3789" title="NM_024529.3:c.766_767delGT and CDC73-Related Disorders" />
        <ClinVarAccession Accession="SCV000041479" DateUpdated="2022-09-24" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">15070940</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">20301744</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="BookShelf">NBK3789</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="80356650" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024529.3:c.766_767delGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0687150" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>SUB12087844</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="41479" TraitType="Disease" MappingType="XRef" MappingValue="C0687150" MappingRef="MedGen">
        <MedGen CUI="C0687150" Name="Parathyroid carcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="23595" TraitType="Disease" MappingType="Name" MappingValue="HYPERPARATHYROIDISM-JAW TUMOR SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1704981" Name="Hyperparathyroidism 2 with jaw tumors" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

